Yousif Capital Management LLC lessened its holdings in shares of Dolby Laboratories (NYSE:DLB – Free Report) by 1.6% during the second quarter, Holdings Channel.com reports. The firm owned 20,597 shares of the electronics maker’s stock after selling 344 shares during the quarter. Yousif Capital Management LLC’s holdings in Dolby Laboratories were worth $1,530,000 at the end of the most recent quarter.
A number of other hedge funds also recently modified their holdings of the business. Vanguard Group Inc. lifted its holdings in shares of Dolby Laboratories by 7.1% during the first quarter. Vanguard Group Inc. now owns 7,535,722 shares of the electronics maker’s stock worth $605,194,000 after purchasing an additional 502,110 shares during the period. Bank of New York Mellon Corp lifted its holdings in shares of Dolby Laboratories by 18.3% during the first quarter. Bank of New York Mellon Corp now owns 5,709,193 shares of the electronics maker’s stock worth $458,505,000 after purchasing an additional 882,716 shares during the period. Mackenzie Financial Corp lifted its holdings in shares of Dolby Laboratories by 17.9% during the first quarter. Mackenzie Financial Corp now owns 1,147,800 shares of the electronics maker’s stock worth $92,180,000 after purchasing an additional 174,373 shares during the period. AQR Capital Management LLC lifted its holdings in shares of Dolby Laboratories by 63.6% during the first quarter. AQR Capital Management LLC now owns 1,143,978 shares of the electronics maker’s stock worth $90,946,000 after purchasing an additional 444,718 shares during the period. Finally, Acadian Asset Management LLC lifted its holdings in shares of Dolby Laboratories by 0.6% during the first quarter. Acadian Asset Management LLC now owns 1,140,821 shares of the electronics maker’s stock worth $91,602,000 after purchasing an additional 6,953 shares during the period. Institutional investors and hedge funds own 58.56% of the company’s stock.
Dolby Laboratories Trading Up 0.9%
DLB opened at $68.79 on Monday. Dolby Laboratories has a 1-year low of $67.54 and a 1-year high of $89.66. The company has a market cap of $6.59 billion, a P/E ratio of 25.20 and a beta of 0.92. The company has a fifty day moving average price of $71.85 and a two-hundred day moving average price of $73.63.
Dolby Laboratories Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were paid a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Tuesday, August 12th. Dolby Laboratories’s payout ratio is 48.35%.
Analysts Set New Price Targets
Several equities analysts recently issued reports on DLB shares. Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a report on Friday, September 5th. Rosenblatt Securities restated a “buy” rating and issued a $95.00 target price on shares of Dolby Laboratories in a report on Friday, August 1st. Weiss Ratings restated a “hold (c)” rating on shares of Dolby Laboratories in a report on Wednesday, October 8th. Tigress Financial boosted their target price on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a “buy” rating in a report on Friday, August 15th. Finally, Robert W. Baird started coverage on shares of Dolby Laboratories in a report on Friday, September 5th. They issued a “neutral” rating and a $74.00 target price on the stock. Three research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $95.75.
View Our Latest Research Report on Dolby Laboratories
Insider Buying and Selling at Dolby Laboratories
In other news, SVP Shriram Revankar sold 7,000 shares of the business’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the sale, the senior vice president directly owned 70,435 shares of the company’s stock, valued at $5,276,990.20. The trade was a 9.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Kevin J. Yeaman sold 25,000 shares of the business’s stock in a transaction dated Tuesday, October 14th. The stock was sold at an average price of $68.87, for a total transaction of $1,721,750.00. Following the sale, the chief executive officer directly owned 114,725 shares of the company’s stock, valued at approximately $7,901,110.75. The trade was a 17.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 82,000 shares of company stock valued at $5,845,440. Insiders own 38.39% of the company’s stock.
About Dolby Laboratories
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
See Also
- Five stocks we like better than Dolby Laboratories
- Top Biotech Stocks: Exploring Innovation Opportunities
- JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Snap-on Incorporated: Snap It Up Quick, New Highs Will Come Soon
- 3 Best Fintech Stocks for a Portfolio Boost
- As Global Renewables Surpass Coal, This ETF Offers Smart Exposure
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.